Key result
The VWF:CB test showed good correlation with VWF:RCo for all VWD types except type 2 and good concordance with multimer pattern, serving as an alternative for diagnosing quantitative VWF deficiencies.
Why the study?
Does the VWF collagen binding test (VWF:CB) improve the diagnosis and classification of von Willebrand disease compared to VWF:RCo and multimer pattern in patients with recurrent bleeding?
Observational (n=19)
Does the VWF collagen binding test (VWF:CB) improve the diagnosis and classification of von Willebrand disease compared to VWF:RCo and multimer pattern in patients with recurrent bleeding?
VWF:CB is a viable alternative to VWF:RCo and multimer pattern for diagnosing quantitative VWF deficiencies, though it does not replace qualitative defect testing.
Answers are grounded in this paper and cite their sources.
Supports VWF:CB as alternative for quantitative VWD diagnosis; leaves open utility in type 2 and routine classification.
Von willebrand disease (VWD) is a common inherited bleeding disorder. The diagnosis may need a large panel of tests that differ in term of sensibility and specificity, and because of the effect of multifactorial modifiers (genetic or environmental); there is difficulty in defining diagnostic limits. We performed a panel of tests on 19 patients suffering from recurrent bleeding, to diagnose and classify VWD subtypes, by introducing the von Willebrand factor (VWF) collagen binding test (VWF:CB), then comparing the results with the activity of VWF risticetin cofactor (VWF:RCo) and multimer pattern. We considered 30% limit rate of VWF, as described by many authors, to make the diagnosis of VWD. The diagnosis of type 1 of VWD has been confirmed in 7patients, subtype 2A in 2 patients, subtype 2M in 2 patients and type 3 in 2 patients. We also defined a new group of 6 patients named "uncertain type 1" that didn't fill into the type 1 diagnostic criterion. The comparison between VWF:CB and VWF:RCo showed good correlation for all types of VWD except for type 2 while comparison between VWF:CB and multimer pattern showed good concordance for all types of VWD diagnosed. In conclusion, VWF:CB can be a good alternative to VWF:RCo for the diagnosis of quantitative deficiencies of VWF. It can also replace the multimer pattern study. However, the introduction of VWF:CB didn't help in the diagnosis of the "uncertain type 1" group of patients and cannot be a replacement for qualitative defect.
No takes yet. Share an insight, caveat, or question.
Ferhat-Hamida et al. (2015) conducted an observational in von Willebrand disease (n=19). von Willebrand factor collagen binding test (VWF:CB) vs. VWF risticetin cofactor (VWF:RCo) and multimer pattern was evaluated on Diagnosis and classification of VWD subtypes. The VWF:CB test showed good correlation with VWF:RCo for all VWD types except type 2 and good concordance with multimer pattern, serving as an alternative for diagnosing quantitative VWF deficiencies.
Synapse has enriched 10 related papers. Consider them for comparative context: